Billionaire Profile
An Kang
Global Rank
#2037

Image: sagindie from Hollywood, USA | CC BY 2.0 | via Wikimedia Commons

An Kang

CEO, Pharmaceuticals
CHINA
Real-Time Net Worth
$2.061B
Estimated based on Pharmaceuticals stock value as of April 20, 2026
-0.58% (24h)
Age
77
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
CHINA

Biography

An Kang, a 77-year-old entrepreneur, is the chairman and largest shareholder of Hualan Biological Engineering, a significant player in the pharmaceuticals industry. He built his wealth through his company, which produces vaccines and blood products. Kang's career includes winning a national science award at age 29. His current net worth is estimated at $2.1 billion, reflecting his successful career and contributions to the healthcare sector.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life and Education

An Kang, a former doctor, demonstrated an early aptitude for science, leading him to win a national science award at the age of 29. He pursued higher education and earned a Bachelor of Arts/Science degree from Henan Normal University.

Rise to Success

An Kang's career is rooted in the pharmaceutical industry, where he serves as chairman and the largest shareholder of Hualan Biological Engineering. This company is a prominent producer of vaccines and blood products, contributing significantly to his wealth.

Key Business Strategies

While specific details about An Kang's business strategies are not widely available, his success in the pharmaceutical sector, particularly in vaccine and blood product manufacturing, highlights his ability to navigate and thrive in the healthcare industry. His leadership has positioned Hualan Biological Engineering as a key player in its field.

Philanthropy

Information regarding An Kang's specific philanthropic activities and amounts is unavailable from the search results.

Career Milestones

Unknown

National Science Award

Awarded at age 29.

Unknown

Chairman and Largest Shareholder

Hualan Biological Engineering.